Kiran Mazumdar-Shaw
Director at Bicara Therapeutics. Based in Boston, Massachusetts.
- Rank
- 14155th of 14,452
- Companies held
- 1
- Largest holding
- BCAX, 100.0% of total
- Latest SEC filing
- Sep 16, 2024
- Listed but not counted
- $53.3M
What the $5.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Bicara Therapeutics BCAX Common Stock | Through Carica Investments | 432,736 | $9.12 | $3.9M | 76.6% | Form 4, Sep 16, 2024 |
| Bicara Therapeutics BCAX Common Stock | Indirectly (see filing footnote) | 115,757 | $9.12 | $1.1M | 20.5% | Form 3, Sep 12, 2024 |
| Bicara Therapeutics BCAX Common Stock | Directly | 16,669 | $9.12 | $152K | 2.9% | Form 3, Sep 12, 2024 |
Share counts are the amounts Kiran Mazumdar-Shaw reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Kiran Mazumdar-Shaw's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Bicara Therapeutics BCAX Common Stock | Through Biocon Limited Held by a company or fund the insider manages | 4,443,122 | $9.12 | $40.5M | — | Form 4, Sep 16, 2024 |
| Bicara Therapeutics BCAX Common Stock | Through Biocon Pharma Inc. Held by a company or fund the insider manages | 1,080,775 | $9.12 | $9.9M | — | Form 4, Sep 16, 2024 |
| Bicara Therapeutics BCAX Common Stock | Through Glentech International Held by a company or fund the insider manages | 324,552 | $9.12 | $3.0M | — | Form 4, Sep 16, 2024 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 14152 | Francisco Fraga EVP, CIO and CTO, McKesson. Irving, TX | $5.2M |
| 14153 | Tony Christianson Director, Titan Machinery. West Fargo, ND | $5.2M |
| 14154 | Demosthenis Pafitis Chief Technology Officer, SLB. Houston, TX | $5.2M |
| 14155 | Kiran Mazumdar-Shaw Director, Bicara Therapeutics. Boston, MA | $5.2M |
| 14156 | Karen M. Camiolo Treasurer & Prin. Fin. Officer, National Fuel Gas. Williamsville, NY | $5.2M |
| 14157 | Chonda J. Nwamu Executive Vice President, Ameren. St. Louis, MO | $5.2M |
| 14158 | Gregory L. Ebel Director, The Mosaic. Tampa, FL | $5.2M |
Questions
How much stock does Kiran Mazumdar-Shaw own?
Kiran Mazumdar-Shaw holds $5,154,277 in listed stock based on SEC filings and current prices, mostly Bicara Therapeutics (BCAX). That ranks 14155th on the Stock Rich List.
Is this Kiran Mazumdar-Shaw's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.